Newsletter
Clinical Trial Update
News filed under Clinical Trial Update, newest first.
Showing 1–5 of 10 stories
Latest story
Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis
Takeda announced new data from three phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279), an...
Read story
Tolerance Bio Licenses TLB-33 From Tanabe Pharma for Global Development
Agreement Gives Tolerance Bio Worldwide Development Rights Outside Japan Tolerance Bio, Inc. has...
Read story
Airway Therapeutics Receives $1.9 Million NIH Grant for Zelpultide Alfa BPD Trial
Funding Will Support U.S. Clinical Development in Extremely Preterm Infants Airway Therapeutics,...
Read story
Vanda Reports Positive Phase III Results for HETLIOZ in Delayed Sleep-Wake Phase Disorder
Phase III Study Meets Primary Endpoint in Adults With DSWPD Vanda Pharmaceuticals Inc. has report...
Read story
Johnson & Johnson Reports Positive Phase 4 STAR Results for Tremfya in Axial Psoriatic Arthritis
Tremfya Meets Main Study Goals in Patients With Axial Involvement Johnson & Johnson has annou...
Read storyPage 1 of 2
